SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacyclics (PCYC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (464)6/28/1999 10:30:00 AM
From: Biomaven  Read Replies (1) of 717
 
Thanks, Rick. One of the things to remember with all the PCYC products is that they are juggling three dosage variables (product dose, light/radiation dose and time elapsed between them) instead of the normal one. This makes Phase I/II that much harder and slower, but also means that there is considerable room left for tweaking to get the best therapeutic index. Sounds to me that for the Lu-Tex family they will move to a longer elapsed time and a bigger light dose.

Results also look good to me at a first glance.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News